MANUFACTURERS LIFE INSURANCE COMPANY, THE - DAY ONE BIOPHARMACEUTICALS I ownership

DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 94 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q3 2022. The put-call ratio across all filers is 0.34 and the average weighting 1.2%.

Quarter-by-quarter ownership
MANUFACTURERS LIFE INSURANCE COMPANY, THE ownership history of DAY ONE BIOPHARMACEUTICALS I
ValueSharesWeighting
Q3 2023$508,174
-33.2%
41,416
-35.0%
0.00%
Q2 2023$760,733
+3.0%
63,713
+15.3%
0.00%
Q1 2023$738,679
-41.3%
55,249
-6.6%
0.00%
-100.0%
Q4 2022$1,259,328
+11.3%
59,154
+3.0%
0.00%0.0%
Q3 2022$1,131,542
+11.5%
57,457
-0.3%
0.00%0.0%
Q2 2022$1,014,761
+138.6%
57,612
+33.4%
0.00%
Q1 2022$425,30943,1770.00%
Other shareholders
DAY ONE BIOPHARMACEUTICALS I shareholders Q3 2022
NameSharesValueWeighting ↓
Canaan Partners XI LLC 6,964,301$139,495,00056.26%
PATHWAY CAPITAL MANAGEMENT, LP 403,127$8,075,00025.88%
Atlas Venture Life Science Advisors, LLC 8,169,171$163,628,00018.06%
RA Capital Management 7,040,622$141,024,0003.01%
COMMODORE CAPITAL LP 739,661$14,815,0002.38%
Nicholas Investment Partners, LP 757,407$15,171,0001.41%
Boxer Capital, LLC 1,189,943$23,835,0001.34%
Parkman Healthcare Partners LLC 212,191$4,250,0001.21%
TANG CAPITAL MANAGEMENT LLC 400,000$8,012,0000.98%
Samsara BioCapital, LLC 196,425$3,934,0000.92%
View complete list of DAY ONE BIOPHARMACEUTICALS I shareholders